Jan 23, 2013
1:12
For every 12 shares held, investors received 1.
The split itself did not change the total investment value.
Oramed Pharmaceuticals Inc. (TASE:ORMP) operates in the Pharmaceuticals: major industry.
Oramed Pharmaceuticals Inc. company overviewOramed Pharmaceuticals Inc.'s most recent stock split was on January 23, 2013. It was a 1-for-12 reverse split, so shareholders received 1 share for every 12 they held.
Oramed Pharmaceuticals Inc. (TASE:ORMP) has split its stock 2 times: a 33-for-10 split on June 14, 2004 and a 1-for-12 reverse split on January 23, 2013.
Oramed Pharmaceuticals Inc. has split its stock 2 times. This history records 2 splits between June 14, 2004 and January 23, 2013.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Oramed Pharmaceuticals Inc.'s 1-for-12 reverse split on January 23, 2013, every 12 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Oramed Pharmaceuticals Inc. has not announced a new split in our records. Its most recent split was on January 23, 2013, 13 years ago. Companies announce splits in advance, and any new TASE:ORMP split will appear on this page.